Location of Repository

The effect of severity of pre-eclampsia on the basal plate intervillous surface lining components: A confocal laser scanning microscopy study

By Bismarck Afedo Hottor


Using immunofluoresce microscopy and histology, intervillous surface lining components area fractions were measured in healthy term chorionic plate (CP) (n=7), healthy term placental basal plate (n=11), mild pre-eclamptic (MPE) placental basal plate (n=10) and severe pre-eclamptic (SPE) placental basal plate (n=11). The aims are (1) to examine the effect of pre-eclampsia (PE) and its severity on the basal plate (BP) intervillous surface lining composition and (2) to define the composition of the CP intervillous surface lining. The results show the mean birth weight of the babies in the SPE are significantly lower than in the HC and MPE (F (2, 29) = 11.912, p =0.000) and the mean gestational age at delivery (GAD) in the SPE group is significantly lower than the HC and MPE (GAD) [Anova p = 0.001; posthoc, p =0.003 and p = 0.001 for MPE and healthy control (HC) respectively]. The mean anchoring villi (AV) to fibrin (NS) ratio of the BP intervillous surface lining is significantly lower in the SPE compared to MPE and the HC groups (ANOVA, p = 0.010; posthoc p = 0.009 and p = 0.628 for HC and MPE respectively) indicating increase fibrin deposition on the basal plate and decreasing anchoring villi attachment area with increasing severity of pre-eclampsia. There are no significant differences in the mean length fractions of endothelium and trophoblast between the 3 groups (Anova, p= 0.107 and p = 0.131 respectively). CP intervillous surface is lined partly by endothelium, trophoblast and an acellular material (fibrin/fibrinoid). Conclusions: (1) The inverse relationship between the proportions of fibrin and anchoring villi with increasing severity of pre-eclampsia indicates that increase deposition of the BP fibrin and poor trophoblast invasion of the BP underlies the disease progression. (2) The CP is partly endothelial contrary to the widely accepted view of wholly trophoblast

Publisher: University of Leicester
Year: 2009
OAI identifier: oai:lra.le.ac.uk:2381/7885

Suggested articles



  1. (1991). 92-kD type IV collagenase mediates invasion of human cytotrophoblasts.
  2. (1982). A cell spreading factor, abundant in human placenta, contains fibronectin and fibrinogen.
  3. (1990). A class I antigen, HLA-G, expressed in human trophoblasts.
  4. (1987). A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term.
  5. (1995). A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia.
  6. (2007). A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.
  7. (2003). A prospective comparison of total protein/creatinine ratio versus 24-hour urine protein in women with suspected preeclampsia.
  8. (1998). A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia.
  9. (1992). A randomized prospective comparison of nifedipine and bed rest versus bed rest alone in the management of preeclampsia remote from term.
  10. (2006). A single serum test for measuring early pregnancy outcome with high predictive value.
  11. (2004). A small randomised trial of low-dose aspirin in women at high risk of pre-eclampsia.
  12. (2000). A Stereological Method for Testing Whether or Not There is Random Deposition of Perivillous Fibrin-type Fibrinoid at the Villous Surface: Description and Pilot Applications to Term Placentae.
  13. (1994). A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies.
  14. (1998). A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation.
  15. (2001). ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques.
  16. (1985). Abnormal placentation.
  17. (1972). About the existence of a specific enzyme for the synthesis of glucuronic acid in the human amnion [Über das Vorkommen eines spezifischen Enzyms der Glucuronsäurebildung im menschlichen Amnion]. Zeitschrift für Zellforschung und Mikroskopische Anatomie,
  18. (2004). Accuracy of urinalysis dipstick techniques in predicting significant proteinuria in pregnancy.
  19. (2002). ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia.
  20. Activin A and inhibin A as possible endocrine markers for preeclampsia.
  21. (1989). Adhesive and degradative properties of human placental cytotrophoblast cells in vitro.
  22. (1990). Aggressive or expectant management for patients with severe preeclampsia between 28-34 weeks' gestation: a randomized controlled trial.
  23. (1994). Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial.
  24. (2000). Amniotic membrane as a substrate for cultivating limbal corneal epithelial cells for autologous transplantation in rabbits.
  25. (1988). Anatomical studies of the utero-placental vascularization in the first trimester of pregnancy.
  26. (1995). Antiadhesive glycosylation of fibronectin-like molecules in human placental matrix-type fibrinoid.
  27. (1997). Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi.
  28. (2007). Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.
  29. (1996). Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast.
  30. (1998). Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia.
  31. (1995). Biochemical corroboration of endothelial involvement in severe preeclampsia.
  32. (1998). Biochemistry and genetics of von Willebrand factor.
  33. (1993). Biology and facultative secretion of plasminogen activator inhibitor-2. Thrombosis and Haemostasis,
  34. (1995). Blindness associated with preeclampsia and eclampsia.
  35. (1989). Capillary permeability and extracellular fluid volumes in pregnancy-induced hypertension.
  36. (2000). Cell-cell-communication during placental development and possible implications for trophoblast proliferation and differentiation.
  37. (1986). Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thrombosis and Haemostasis,
  38. (1996). Change in paternity: a risk factor for preeclampsia in multiparas.
  39. (2005). Characterization of new members of the human type II keratin gene family and a general evaluation of the keratin gene domain on chromosome 12q13.13.
  40. (1992). Characterization of the membrane attack complex inhibitory protein CD59 antigen on human amniotic cells and in amniotic fluid.
  41. (2002). Chorionic gonadotropin has a recent origin within primates and an evolutionary history of selection.
  42. (2004). Circulating Angiogenic Factors and the Risk of Preeclampsia.
  43. (1997). Classification of human placental stem villi: Review of structural and functional aspects.
  44. (1988). Clinicopathological study of neurological complications due to hypertensive disorders of pregnancy.
  45. (2002). Clotting and hemorrhage in the placenta - A delicate balance.
  46. (1996). Coagulation and fibrinolysis in smoking and nonsmoking pregnant women.
  47. (1993). Confocal and conventional immunofluorescence and ultrastructural localisation of intracellular strength-giving components of human amniochorion.
  48. (1993). Confocal immunofluorescence localization of collagen types I, III, IV, V and VI and their ultrastructural organization in term human fetal membranes.
  49. (2004). Confocal laser scanning microscope study of cytokeratin immunofluorescence differences between villous and extravillous trophoblast: cytokeratin downregulation in pre-eclampsia.
  50. (2002). Connexin expression and gap junctional intercellular communication in human first trimester trophoblast. Molecular Human Reproduction,
  51. (1995). Control of peripartal collagenolysis in the human chorion-decidua.
  52. (1999). Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia.
  53. (1995). Corticotrophin-releasing hormone and corticotrophin-releasing hormone binding protein in normal and pre-eclamptic human pregnancies.
  54. (2006). Cost-savings analysis of an outpatient management program for women with pregnancy-related hypertensive conditions.
  55. (1994). Cryofracture of human term amniochorion.
  56. (1991). Current topic. Pre-eclampsia and the placenta.
  57. (1972). Decidual Cell Production of Human Placental Fibrinoid.
  58. (2000). Denudations as paracellular routes for alphafetoprotein and creatinine across the human syncytiotrophoblast.
  59. (1999). Detection of soluble HLA-G molecules in plasma and amniotic fluid.
  60. (1960). Development of the human placenta in the first three months of gestation.
  61. (1994). Developmental expression of Ki-67 antigen and proliferating cell nuclear antigen in macaque placentas.
  62. (2004). Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count.
  63. (1988). Differential expression of blood-group-related carbohydrate antigens by trophoblast subpopulations.
  64. (2002). Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: Preliminary characterization of the hyperglycosylated hCG epitope.
  65. (1994). Differential lectin binding to the fibrinoid of human full-term placenta: correlation with a fibrin antibody and the PAF-Halmi method.
  66. (1990). Differentiatio-specfic expression of keratin pairs.
  67. (1993). Differentiation and proliferation patterns in human trophoblast revealed by cerbB-2 oncogene product and EGF-R.
  68. (1994). Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes.
  69. (1995). Differentiation of endothelium.
  70. (1995). Differentiation of human trophoblast populations involves alterations in cytokeratin patterns.
  71. (1992). Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo.
  72. (2002). Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebocontrolled trial.
  73. (1978). Early platelet consumption in pre-eclampsia.
  74. (2003). Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia.
  75. (1992). Embryology colouring book London:
  76. (2003). Endothelial cell diversity revealed by global expression profiling.
  77. (2003). Endothelial cell functions.
  78. (1998). Endothelial dysfunction in preeclampsia.
  79. (2003). Endovascular Trophoblast Invasion: Implications for the Pathogenesis of Intrauterine Growth Retardation and Preeclampsia.
  80. (1989). Enhanced thrombin generation in normal and hypertensive pregnancy.
  81. (1990). Epidemiology of preeclampsia and eclampsia in the United States,
  82. (1999). Evaluation of a definition of preeclampsia.
  83. (1997). Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody.
  84. (1998). Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Molecular Human Reproduction,
  85. (1996). Evidence for the expression of HLA-C class I mRNA and protein by human first trimester trophoblast.
  86. (2004). Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award.
  87. (2003). Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia.
  88. (2006). Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction.
  89. (2000). Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia.
  90. (1995). Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
  91. (2007). Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications.
  92. (1994). Expression of adhesion molecules by endovascular trophoblast and decidual endothelial cells: Implications for vascular invasion during implantation.
  93. (1994). Expression of C-kit and kit ligand at the human maternofetal interface.
  94. (1991). Expression of extracellular matrix-degrading metalloproteinases by cultured human cytotrophoblast cells: effects of cell adhesion and immunopurification.
  95. (1994). Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium.
  96. (1993). Expression of integrin [alpha]6[beta]4 in human trophoblast and its loss from extravillous cells.
  97. (1993). Expression of integrins by human trophoblast and differential adhesion to laminin or fibronectin.
  98. (1993). Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface.
  99. (1994). Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta.
  100. (1988). Expression of the proliferation markers Ki67 and transferrin receptor by human trophoblast populations.
  101. (1999). Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta.
  102. (1997). Extensive platelet activation in preeclampsia compared with normal pregnancy: Enhanced expression of cell adhesion molecules.
  103. (1992). Extracellular fluid volumes in pregnancyinduced hypertension.
  104. (1996). Extracellular matrix components of the placental extravillous trophoblast: immunocytochemistry and ultrastructural distribution.
  105. (1997). Extravillous trophoblast in the human placenta: A review.
  106. (1993). Extravillous trophoblast: Immunohistochemical localization of extracellular matrix molecules.
  107. (1977). Fetal growth retardation and the arteries of the placental bed.
  108. (1967). Fetomaternal cellular relations in the human basal plate: an ultrastructural study of the placenta.
  109. (1983). Fibrin as a component of the tumor stroma: origins and biological significance.
  110. (1965). Fibrinolysis and Plasminogen levels in pregnancy and the puerperium.
  111. (1994). Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy.
  112. (2007). Genetic origin and proportion of basal plate surface-lining cells in normal and abnormal pregnancies.
  113. (1988). Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy.
  114. (2006). Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG.
  115. (1959). Glomerular capillary endotheliosis in toxemia of pregnancy.
  116. (2003). Haemostatic mechanisms in human placenta.
  117. (2004). Healthy and preeclamptic placental basal plate lining cells: quantitative comparisons based on confocal laser scanning microscopy.
  118. (1985). Hemodynamic observations in severe preeclampsia complicated by pulmonary edema.
  119. (1996). Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications.
  120. (1991). High plasma cellular fibronectin levels correlate with biochemical and clinical features of preeclampsia but cannot be attributed to hypertension alone.
  121. (1955). Histochemical studies on the human placenta with special consideration of nuclear globes (nuclear inclusions) and plasma lipoid inclusions.]. Zeitschrift fur Anatomie und Entwicklungsgeschichte,
  122. (1969). Histological and histochemical study of the extracellular deposits in the normal human placenta.
  123. (1985). Histomorphometry of the human placenta in maternal preeclampsia.
  124. (1987). Histomorphometry of the human placenta in pre-eclampsia associated with severe intrauterine growth retardation.
  125. (2002). History of abortion, preterm, term birth, and risk of preeclampsia: a population-based study.
  126. (2001). HLA Class I protein expression in the human placenta. Early pregnancy
  127. (1993). HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells.
  128. (2000). HLA-E is expressed on trophoblast and interacts with CD94/NKG2 receptors on decidual NK cells.
  129. (1998). HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation.
  130. (2004). Human amniotic epithelial cells possess hepatocyte-like characteristic and functions.
  131. (2007). Human Chorionic Gonadotropin Expression in Human Trophoblasts from Early Placenta: Comparative Study Between Villous and Extravillous Trophoblastic Cells.
  132. (2007). Human chorionic gonadotropin produced by the invasive trophoblast but not the villous trophoblast promotes cell invasion and is downregulated by peroxisome proliferator-activated receptor-?
  133. (1999). Human chorionic gonadotropin promotes tumorigenesis of choriocarcinoma JAr cells.
  134. (1994). Human cytotrophoblast invasion is up-regulated by epidermal growth factor: Evidence that paracrine factors modify this process.
  135. (2006). Human leukocyte antigen F protein is expressed in the extra-villous trophoblasts but not on the cell surface of them.
  136. (1995). Human placental HLA-G expression is restricted to differentiated cytotrophoblasts.
  137. (1990). Human trophoblast cell resistance to decidual NK lysis is due to lack of NK target structure.
  138. (1989). Human trophoblast resistance to decidual NK lysis is due to lack of NK cell target.
  139. (2004). Human uterine leukocytes and pregnancy.
  140. (1998). Human uterine lymphocytes. Human Reproduction Update,
  141. (2003). Hyperglycosylated hCG (Invasive Trophoblast Antigen, ITA) a key antigen for early pregnancy detection.
  142. (2006). Hyperglycosylated hCG in gestational implantation and in choriocarcinoma and testicular germ cell malignancy tumorigenesis.
  143. (2008). Hyperglycosylated human chorionic gonadotropin and human chorionic gonadotropin free Î-subunit: Tumor markers and tumor promoters.
  144. (2004). Hypertension during pregnancy in South Australia, part 1: pregnancy outcomes.
  145. (2006). Hypoxia and reoxygenation: A possible mechanism for placental oxidative stress in preeclampsia.
  146. (2004). Hypoxia and sFlt-1 in Preeclampsia: The "Chickenand-Egg" Question.
  147. (2003). Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation.
  148. (2003). Hypoxia-reoxygenation; a potential source of placental oxidative stress in normal pregnancy and preeclampsia.
  149. (2002). Hypoxiareoxygenation: A potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia.
  150. (1994). Identification of 72-kilodalton type IV collagenase at sites of trophoblastic invasion of macaque spiral arteries.
  151. (1995). Identification of the cadherins present in the human placenta.
  152. (2007). Imitators of severe preeclampsia.
  153. (2001). Immunochemical measurement of early pregnancy isoforms of hCG: Potential applications to fertility research, prenatal diagnosis, and cancer.
  154. (1998). Immunocytochemical localisation of caveolin-1 in human term extra-embryonic membranes using confocal laser scanning microscopy.
  155. (2001). Immunocytochemical localization of a caveolin-1 isorform in human term extra-embryonic membranes using confocal laser scanning microscopy: Implications for the complexity of the materno-fetal junction.
  156. (1988). Immunocytochemical localization of heparan sulfate proteoglycan in human decidual cell secretory bodies and placental fibrinoid.
  157. (1992). Immunohistochemical profile of basement membrane proteins and 72 kilodalton type IV collagenase in the implantation placental site: An integrated view.
  158. (1998). Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta.
  159. (1994). Immunohistochemistry of two different types of placental fibrinoid.
  160. (1971). Immunohistological and elution studies of the human placenta.
  161. (1997). Immunology of human placental implantation: Clinical implications of our current understanding.
  162. (2001). Implantation and the survival of early pregnancy.
  163. (2001). In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies.
  164. (1999). In vivo assessment of failed trophoblastic invasion of the spiral arteries in pre-eclampsia.
  165. (2006). In-situ hybridisation using y-chromosome specific probes to establish the origins of basal plate cells. EMBIC Handbook “Embryo implantation: from basics to clinics” Rijeka:
  166. (1986). Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants.
  167. (1998). Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli.
  168. (2006). Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.
  169. (1996). Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
  170. (2006). Inflammation and preeclampsia.
  171. (1993). Inhibition of Vascular Endothelial Cell Growth Factor Activity by an Endogeneously Encoded Soluble Receptor.
  172. (1994). Integrin switching regulates normal trophoblast invasion.
  173. (1991). Is oncofetal fibronectin a trophoblast glue for human implantation?
  174. (2000). Is the prophylactic administration of magnesium sulphate in women with pre-eclampsia indicated prior to labour? BJOG:
  175. (1966). Is, in the full-term placenta, the Basal plate covered by trophoblast cells or cells of maternal origin.
  176. (1984). Isolation and characterization of thrombomodulin from human placenta.
  177. (2002). KIR: diverse, rapidly evolving receptors of innate and adaptive immunity.
  178. (1975). Light and electron microscopic investigations on the chorionic plate of the human placenta at term[Licht- Und Elektronenmikroskopscheuntersucgungenan Der ChorionPlatte Der Reifen Menschlichen Plazenta] Archiv für Gynakologie,
  179. (1978). Lightmicroscopical and histochemical studies on the chorionic plate of the mature human placenta [Lichtmikroskopischeund histochemische untersuchungen an der chorionplatte der reifen menschlichen placenta] Archiv für Gynakologie,
  180. (2000). Localization and the possible role of plasminogen activators and inhibitors in early stages of placentation.
  181. (1994). Localization of epidermal growth factor receptors in first- and third- trimester human placentas.
  182. (2001). Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study.
  183. (2005). Long-term mortality after preeclampsia.
  184. (2002). Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches.
  185. (2003). Magnesium Sulfate in Women With Mild Preeclampsia: A Randomized Controlled Trial. Obstetrics and Gynecology,
  186. (2003). Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev.
  187. (2003). Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev.
  188. (2001). Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev.
  189. (2003). Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database of Systematic Reviews,
  190. (1978). Management of pregnancy-induced hypertension in the nulliparous patient remote from term. Seminars in Perinatology,
  191. (1974). Manual of Histological Demonstration Techniques London Butterworths.
  192. (1975). Massive subchorial thrombohaematoma (Breus'
  193. (1987). Massive subchorionic thrombohaematoma presenting as a placental tumour. Case report.
  194. (1999). Maternal arterial connections to the placental intervillous space during the first trimester of human pregnancy: The Boyd Collection revisited.
  195. (2003). Maternal diabetes mellitus is associated with altered deposition of fibrin-type fibrinoid at the villous surface in term placentae.
  196. (1992). Maternal mortality associated with hypertensive disorders of pregnancy in
  197. (2006). Maternal mortality in the Greater Accra region in Ghana: Assessing completeness of registration and data quality.
  198. (2000). Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom.
  199. (1995). Mechanisms of alphafetoprotein transfer in the perfused human placental cotyledon from uncomplicated pregnancy.
  200. (1992). Mechanisms of placental invasion of the uterus and their control.
  201. (2005). MHC class I molecules and KIRs in human history, health and survival.
  202. (1993). Micro-trabeculae, macro-plaques or mini-basement membranes in human term fetal membranes?
  203. (1998). Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display.
  204. (1994). Monitored outpatient management of mild gestational hypertension remote from term.
  205. (1983). Monoclonal antibodies to a synthetic fibrinlike peptide bind to human fibrin but not fibrinogen.
  206. (1981). Morphogenesis of human placental chorionic villi: cytoskeletal, syncytioskeletal and extracellular matrix proteins.
  207. (1975). Morphological pathology of the placenta. The Placenta and its Maternal Supply Line: Effects of Insufficiency on the Fetus,
  208. (1935). Mütterlicher und kindlicher Kreislauf der menschlichen Placenta und seine Strombahnen - Mit Unterstützung aus Mitteln der deutschen Forschungsgemeinschaft. Zeitschrift für Anatomie und Entwicklungsgeschichte,
  209. (2000). Myofibroblast differentiation in the connective tissues of the amnion and chorion of term human fetal membranes - Implications for fetal membrane rupture and labour.
  210. (1995). n vitro invasion of first trimester human trophoblast: Localisation of Ecadherin and MMP-9.
  211. (2002). Natural killer cells and pregnancy.
  212. (1995). Neural cell adhesion molecule is present on macaque intra-arterial cytotrophoblast.
  213. (2003). Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria.
  214. (2008). NK cells and pre-eclampsia.
  215. (1999). Normal expression of tissue factor, thrombomodulin, and annexin V in placentas from women with antiphospholipid syndrome.
  216. (1999). Objective evidence of endothelial dysfunction in preeclampsia.
  217. (1998). Obstetric and perinatal outcome after oocyte donation: comparison with in-vitro fertilization pregnancies.
  218. Onset of maternal arterial blood flow and placental oxidative stress: A possible factor in human early pregnancy failure.
  219. (1974). Origin of placental infarcts.
  220. (2003). Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences.
  221. (1992). Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy.
  222. (1967). Perivillous fibrin deposition in the human placenta.
  223. (2001). Phenotype of the endothelium in the human term placenta.
  224. (1991). Physiology of pregnancy.
  225. (1989). Placental and decidual u-PA, tPA, PAI-1 and PAI-2 concentrations, as affected by cervical dilatation with laminaria tents or hegar dilators.
  226. (1991). Placental bed spiral arteries in the hypertensive disorders of pregnancy.
  227. (2008). Placental morphometrical and histopathology changes in the different clinical presentations of Hypertensive Syndromes in Pregnancy.
  228. (2004). Placental Oxidative Stress: From Miscarriage to Preeclampsia.
  229. (1997). Placental pathology of fetal growth restriction.
  230. (1985). Placental plasminogen activator activity in pre-eclampsia.
  231. (2009). Placental Stress and Pre-eclampsia: A Revised View.
  232. (2006). Placental-related diseases of pregnancy: Involvement of oxidative stress and implications in human evolution. Human Reproduction Update,
  233. (1976). Plasma fibrinolytic activity in pregnancy with particular reference to pre eclampsia.
  234. (1982). Plasma fibrinopeptide A and betathromboglobulin in pre-eclampsia and pregnancy hypertension. Thrombosis and Haemostasis,
  235. (1989). Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts.
  236. (1997). Polymorphism and domain variability of human killer cell inhibitory receptors.
  237. (2005). Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement.
  238. (1992). Pre-eclampsia : the facts : the hidden threat to pregnancy:
  239. (2007). Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis.
  240. (1985). Pre-eclampsia in second pregnancy.
  241. (2002). Prediction of 24-hour protein excretion in pregnancy with a single voided urine protein-to-creatinine ratio.
  242. (2000). Preeclampsia and fetal growth.
  243. (2003). Preeclampsia and human reproduction. An essay of a long term reflection.
  244. (1993). Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts.
  245. (1997). Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: One cause of defective endovascular invasion in this syndrome?
  246. (2003). Preeclampsia, the Placenta and The Maternal Systemic Inflammatory Respose.
  247. (1989). Preeclampsia: An endothelial cell disorder.
  248. (1999). Preeclampsia: An excessive maternal inflammatory response to pregnancy.
  249. (1985). Preeclampsia: An imbalance in placental prostacyclin and thromboxane production.
  250. (1997). Preeclampsia: Immunologic alteration of Nitabuch's membrane? Clinical sequelae.
  251. (2003). Preeclampsia/eclampsia and the evolution of the human brain.
  252. (2001). Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.
  253. Pregnancy outcome after eclampsia and long-term prognosis.
  254. (2000). Pregnancy outcomes in healthy nulliparas who developed hypertension.
  255. (2001). Pregnancy-related mortality from preeclampsia and eclampsia.
  256. (2002). Preventing and treating eclamptic seizures.
  257. (2005). Project 27/28: inquiry into quality of neonatal care and its effect on the survival of infants who were born at 27 and 28 weeks in England,
  258. (1996). Properties of connexin40 gap junction channels endogenously expressed and exogenously overexpressed in human
  259. (1996). Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.
  260. (2003). Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.
  261. (1992). Proteolysis in the penetration phase of the implantation process.
  262. (1990). Proteolytic activity of first trimester human placenta: Localization of interstitial collagenase in villous and extravillous trophoblast.
  263. (1985). Purification of a specific placental plasminogen activator inhibitor by monoclonal antibody and its complex formation with plasminogen activator.
  264. (1966). Quantitative aspects of placental structure.
  265. (1994). Reciprocal expression of epidermal growth factor receptor (EGF-R) and c-erbB2 by non-invasive and invasive human trophoblast populations.
  266. (2005). Recommendations for Blood Pressure Measurement
  267. (1999). Reducing unnecessary coagulation testing in hypertensive disorders of pregnancy.
  268. (1994). Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion.
  269. (1981). Relative brain size and basal metabolic rate in terrestrial vertebrates.
  270. (1994). Renal pathology in pre-eclampsia.
  271. (2000). Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.
  272. (1994). Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells.
  273. (1959). Review of normal and pathological glomerular ultrastructures.
  274. (2005). Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.
  275. (2003). Risk of subsequent thromboembolism for patients with pre-eclampsia.
  276. (1996). Scaling of the mammalian brain: The maternal energy hypothesis.
  277. (1989). Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.
  278. (1976). Sequential studies on components of the haemostatic mechanism in pregnancy with particular reference to the development of pre eclampsia.
  279. (2008). Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: Hypoxic regulation via transforming growth factor-Î3.
  280. (1991). Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis.
  281. (1986). Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis.
  282. (1998). Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies.
  283. (2000). Should the definition of preeclampsia include a rise in diastolic blood pressure of ≥15 mm Hg to a level <90 mm Hg in association with proteinuria?
  284. (1992). Simultaneous expression of 70 kilodalton type IV collagenase and type IV collagen ?1(IV) chain genes by cells of early human placenta and gestational endometrium.
  285. (2006). Soluble endoglin contributes to the pathogenesis of preeclampsia.
  286. (1998). Solving the brain's energy crisis.
  287. (1965). Some anomalies of the foetal vessels of the human placenta.
  288. (1953). Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates.
  289. (1998). Specific expression of PP5/TFPI-2 mRNA by syncytiotrophoblasts in human placenta as revealed by in situ hybridization.
  290. (1962). Studies on the character and staining of fibrin.
  291. (2000). Surface expression of HLA-C antigen by human extravillous trophoblast.
  292. (2009). Syncytial knots, sprouts, apoptosis, and trophoblast deportation from the human placenta.
  293. (1984). Syncytioskeletons in choriocarcinoma in culture.
  294. (1979). The amnion in surgery, past and present.
  295. (1966). The anatomy of the human amnion and chorion.
  296. (2004). The association between hyaline membrane disease and preeclampsia.
  297. (1982). The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells.
  298. (1996). The distribution of tissue inhibitor of metalloproteinases-2 (TIMP-2) in the human placenta.
  299. (1997). The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial.
  300. (1994). The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: Immunolocalization and in vitro regulation.
  301. (1996). The fibrinoids of the human placenta: origin, composition and functional relevance.
  302. (2000). The genomic organization and evolution of the natural killer immunoglobulin-like receptor (KIR) gene cluster.
  303. (1990). The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing?
  304. (1962). The Human Amnion and Chorion.
  305. (1970). The human placenta Cambridge: W.Heffer and
  306. (2000). The human placenta is encircled by a ring of smooth muscle cells.
  307. (2004). The human type I keratin gene family: Characterization of new hair follicle specific members and evaluation of the chromosome 17q21.2 gene domain.
  308. (2006). The impact of the interaction between increasing gestational age and obstetrical risk on birth outcomes: evidence of a varying optimal time of delivery.
  309. (1993). The importance of energy and nutrient supply in human brain evolution. Nutrition and health
  310. (1996). The importance of urinary protein excretion during conservative management of severe preeclampsia.
  311. (1979). The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme function.
  312. (2002). The killer cell immunoglobulinlike receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.
  313. (1967). The masking of antigens on trophoblast and cancer cells.
  314. (1990). The measurement of blood pressure: sitting or supine, once or twice?
  315. (1960). The microscopic anatomy of the human amnion and chorion.
  316. (1966). The morphology of human uteroplacental vasculature.
  317. (1959). The natural history of choriocarcinoma: Problems of immunity and spontaneous regression.
  318. (1987). The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma hCG.
  319. (1967). The pathological response of the vessels of the placental bed to hypertensive pregnancy.
  320. (1967). The physiological response of the vessels of the placental bed to normal pregnancy.
  321. (1996). The placental bed.
  322. (2003). The Potential Role of HLA-G Polymorphism in Maternal Tolerance to the Developing Fetus.
  323. (1980). The predictive value of serum haptoglobin in hemolytic disease.
  324. (1982). The protein composition of the fibrinoid material at the human uteroplacental interface.
  325. (2004). The renal response to preeclampsia.
  326. (2002). The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia.
  327. (1972). The role of the spiral arteries in the pathogenesis of preeclampsia.
  328. (1999). The role of trophoblast in the physiological change of decidual spiral arteries.
  329. (1976). The trophoblasts of the chorionic plate of mature human placentas [Uber dentrophoblasten der chorionplatte Reifermenschlicher plazenten]
  330. (1995). The value of routine urine dipstick screening for protein at each prenatal visit.
  331. (1982). Theory and practice of histological techniques 2nd ed.
  332. (1976). Thrombin clottable determination of plasma fibrinogen in pregnancy.
  333. (1985). Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta.
  334. (1985). Tissue factor (coagulation factor III) is present in placental microvilli and cofractionates with microvilli membrane proteins.
  335. (1995). Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in culture.
  336. (2006). TNFα-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells.
  337. (1986). Transcapillary fluid balance in pre-eclampsia.
  338. (2005). Transfection of antisense chorionic gonadotropin ? gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis.
  339. (1996). Treatment of hypertension in pregnant women.
  340. (1991). Trophoblast deportation in preeclamptic pregnancy.
  341. (2004). Trophoblast differentiation during embryo implantation and formation of the maternal-fetal interface.
  342. (1990). Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta.
  343. (2002). Trophoblast origin of hCG isoforms: Cytotrophoblasts are the primary source of choriocarcinoma-like hCG.
  344. (1993). Trophoblastic invasion and the development of uteroplacental arteries in the macaque: Immunohistochemical localization of cytokeratins, desmin, type IV collagen, laminin, and fibronectin.
  345. (1980). Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy.
  346. (1971). Ultrastructure of human amnion and amniotic plaques of normal pregnancy. Zeitschrift für Zellforschung und Mikroskopische Anatomie,
  347. (1971). Ultrastructure of the anchoring villi and trophoblastic shell in the second week of placentation.
  348. (1968). Ultrastructure of the human amnion, chorion and fetal skin.
  349. (1995). Ultrastructure of the materno-embryonic interface in the first trimester of pregnancy.
  350. (1973). Ultrastructure of the spiral arteries in the human placental bed at the end of normal pregnancy.
  351. (1994). Urinary dipstick protein: A poor predictor of absent or severe proteinuria.
  352. (2002). Urinary protein excretion and expectant management of early onset, severe pre-eclampsia.
  353. (2001). Use of a random urinary protein-tocreatinine ratio for the diagnosis of significant proteinuria during pregnancy.
  354. (1983). Use of single voided urine samples to estimate quantitative proteinuria.
  355. (1996). Use of the protein/creatinine ratio of a single voided urine specimen in the evaluation of suspected pregnancy-induced hypertension.
  356. (2005). Usefulness of aspirin therapy in
  357. (1983). Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy.
  358. (2002). Vascular Endothelial Growth Factor Ligands and Receptors That Regulate Human Cytotrophoblast Survival Are Dysregulated in Severe Preeclampsia and Hemolysis, Elevated Liver Enzymes, and Low Platelets Syndrome.
  359. (1998). Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta.
  360. (2001). Villous trophoblast: Morphometric perspectives on growth, differentiation, turnover and deposition of fibrin-type fibrinoid during gestation.
  361. (2006). Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.
  362. (2009). World Health Organisation multicentre randomised trial of supplementation with vitamins C and e among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.